Factors predicting the outcome of allergen-specific nasal provocation test in children with grass pollen allergic rhinitis.
component-resolved diagnostics
e-Diary
nasal provocation test (NPT)
pollen allergy
precision medicine
seasonal allergic rhinitis
Journal
Frontiers in allergy
ISSN: 2673-6101
Titre abrégé: Front Allergy
Pays: Switzerland
ID NLM: 9918227355906676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
03
2023
accepted:
08
05
2023
medline:
12
6
2023
pubmed:
12
6
2023
entrez:
12
6
2023
Statut:
epublish
Résumé
Nasal provocation testing (NPT) is a reference methodology to identify the culprit allergen in patients with allergic rhinitis. Selecting the right allergen for NPT is particularly difficult in poly-sensitized patients with seasonal allergic rhinitis (SAR). Predictors of NPT outcomes may facilitate the proper use of this test or even substitute it. To identify predictors of grass pollen NPT outcome from an array of clinical data, e-diary outcomes, and allergy test results in poly-sensitized pediatric patients with SAR. Poly-sensitized, SAR patients with grass pollen allergy, participating in the @IT.2020 pilot project in Rome and Pordenone (Italy), participated in a baseline (T0) visit with questionnaires, skin prick testing (SPT), and blood sampling to measure total (ImmunoCAP, TFS, Sweden) and specific IgE antibodies to grass pollen extracts and their major allergenic molecules (ESEP, Euroimmun Labordiagnostika, Germany). During the pollen season, patients filled the AllergyMonitor® e-diary app measuring their symptoms, medication intake, and allergy-related well-being via the Visual Analogue Scale (VAS). After the pollen season (T1), patients answered clinical questionnaires and underwent a nasal provocation test (NPT) with grass pollen extract. We recruited 72 patients (age 14.3 ± 2.8 years, 46 males) sensitized to grass and/or other pollens, including olive (63; 87.5%) and pellitory (49; 68.1%). Patients positive to grass pollen NPT (61; 84.7%), compared to the negative ones, had worse VAS values in the e-diary, larger SPT wheal reactions, and higher IgE levels, as well as specific activity to timothy and Bermuda grass extracts, rPhl p 5 and nCyn d 1. A positive NPT to grass pollen was predicted by an index combining the specific activity of IgE towards Phl p 5 and Cyn d 1 (AUC: 0.82; An index combining the specific activity of IgE to rPhl p 5 and nCyn d 1 predicted with moderate sensitivity and high specificity the outcome of a grass pollen NPT in complex, poly-sensitized pediatric patients with seasonal allergic rhinitis. Further studies are needed to improve the index sensitivity and to assess its usefulness for NPT allergen selection or as an alternative to this demanding test procedure.
Sections du résumé
Background
UNASSIGNED
Nasal provocation testing (NPT) is a reference methodology to identify the culprit allergen in patients with allergic rhinitis. Selecting the right allergen for NPT is particularly difficult in poly-sensitized patients with seasonal allergic rhinitis (SAR). Predictors of NPT outcomes may facilitate the proper use of this test or even substitute it.
Objective
UNASSIGNED
To identify predictors of grass pollen NPT outcome from an array of clinical data, e-diary outcomes, and allergy test results in poly-sensitized pediatric patients with SAR.
Methods
UNASSIGNED
Poly-sensitized, SAR patients with grass pollen allergy, participating in the @IT.2020 pilot project in Rome and Pordenone (Italy), participated in a baseline (T0) visit with questionnaires, skin prick testing (SPT), and blood sampling to measure total (ImmunoCAP, TFS, Sweden) and specific IgE antibodies to grass pollen extracts and their major allergenic molecules (ESEP, Euroimmun Labordiagnostika, Germany). During the pollen season, patients filled the AllergyMonitor® e-diary app measuring their symptoms, medication intake, and allergy-related well-being via the Visual Analogue Scale (VAS). After the pollen season (T1), patients answered clinical questionnaires and underwent a nasal provocation test (NPT) with grass pollen extract.
Results
UNASSIGNED
We recruited 72 patients (age 14.3 ± 2.8 years, 46 males) sensitized to grass and/or other pollens, including olive (63; 87.5%) and pellitory (49; 68.1%). Patients positive to grass pollen NPT (61; 84.7%), compared to the negative ones, had worse VAS values in the e-diary, larger SPT wheal reactions, and higher IgE levels, as well as specific activity to timothy and Bermuda grass extracts, rPhl p 5 and nCyn d 1. A positive NPT to grass pollen was predicted by an index combining the specific activity of IgE towards Phl p 5 and Cyn d 1 (AUC: 0.82;
Conclusions
UNASSIGNED
An index combining the specific activity of IgE to rPhl p 5 and nCyn d 1 predicted with moderate sensitivity and high specificity the outcome of a grass pollen NPT in complex, poly-sensitized pediatric patients with seasonal allergic rhinitis. Further studies are needed to improve the index sensitivity and to assess its usefulness for NPT allergen selection or as an alternative to this demanding test procedure.
Identifiants
pubmed: 37304166
doi: 10.3389/falgy.2023.1186353
pmc: PMC10250668
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1186353Informations de copyright
© 2023 Barreto, Tripodi, Arasi, Landi, Montesano, Pelosi, Potapova, Sfika, Villella, Travaglini, Brighetti, Matricardi and Dramburg.
Déclaration de conflit d'intérêts
PMM reports grants and personal fees from EUROIMMUN AG, during the conduct of the study; and grants and personal fees from Thermo Fisher Scientific, and personal fees from Hycor Biomedical Inc, outside the submitted work. ST is cofounder of TPS Production. SP reports personal fees from TPS Production. SD reports personal fees from OMRON Healthcare, dbv Technologies, Allergopharma and Bencard Allergie outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Allergy. 2018 Apr;73(4):765-798
pubmed: 28940458
J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):300-5
pubmed: 24811021
Allergy. 2018 Aug;73(8):1597-1608
pubmed: 29377177
Allergol Int. 2012 Jun;61(2):339-46
pubmed: 22526205
Clin Allergy. 1975 Dec;5(4):431-42
pubmed: 1053442
Am J Rhinol Allergy. 2016 Jan-Feb;30(1):60-4
pubmed: 26867532
Otolaryngol Head Neck Surg. 2004 Sep;131(3):215-9
pubmed: 15365538
Clin Exp Allergy. 2014 Nov;44(11):1409-19
pubmed: 25262820
Immunol Res. 2010 Jul;47(1-3):273-84
pubmed: 20066506
J Allergy Clin Immunol. 2011 Mar;127(3):633-9.e1-3
pubmed: 21377032
Allergy. 2011 Jun;66(6):775-83
pubmed: 21352238
Acta Biomed. 2020 Sep 15;91(11-S):e2020012
pubmed: 33004782
J Investig Allergol Clin Immunol. 2016;26(3):204-7
pubmed: 27326995
Ann Allergy Asthma Immunol. 2007 Feb;98(2):134-8
pubmed: 17304879
Clin Exp Allergy. 2014;44(5):778-86
pubmed: 24598010
Clin Mol Allergy. 2013 Dec 05;11(1):3
pubmed: 24308506
Allergy Asthma Clin Immunol. 2016 Apr 27;12:20
pubmed: 27127526
Allergy. 2020 Jul;75(7):1659-1671
pubmed: 31833579
Clin Transl Allergy. 2021 Dec 15;11(10):e12084
pubmed: 34950450
Ann Allergy Asthma Immunol. 2004 Jun;92(6):604-10
pubmed: 15237761
Pediatr Allergy Immunol. 2018 Dec;29(8):841-849
pubmed: 30144162
Allergy. 1986 Aug;41(6):398-407
pubmed: 3789325
Clin Exp Allergy. 2011 Aug;41(8):1116-24
pubmed: 21518042
Int Arch Allergy Immunol. 2019;179(2):108-113
pubmed: 30970353
Allergy. 2007 Apr;62(4):367-72
pubmed: 17362246
Am J Rhinol Allergy. 2022 Mar;36(2):191-197
pubmed: 34388048
Laryngorhinootologie. 2003 Mar;82(3):183-8
pubmed: 12673517
J Allergy Clin Immunol. 2021 Aug;148(2):495-505.e14
pubmed: 33675817
Pediatr Allergy Immunol. 2016 Jun;27(4):382-90
pubmed: 26992008
Clin Exp Allergy. 2021 Jun;51(6):821-828
pubmed: 33759270
Lancet. 2011 Dec 17;378(9809):2112-22
pubmed: 21783242
Clin Exp Allergy. 2011 Aug;41(8):1048-9
pubmed: 21752113
Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352
pubmed: 29438602
Allergy. 2023 Feb;78(2):550-553
pubmed: 36037276
Pediatr Allergy Immunol. 2021 Feb;32(2):223-233
pubmed: 33020989
Am J Rhinol Allergy. 2015 Jul-Aug;29(4):e100-4
pubmed: 26163237
Ital J Pediatr. 2020 Jul 25;46(1):105
pubmed: 32711557
Eur Ann Allergy Clin Immunol. 2014 Nov;46(6):216-25
pubmed: 25398165
J Allergy Clin Immunol. 2020 Nov;146(5):1097-1108
pubmed: 32298697
Am J Rhinol Allergy. 2018 Jul;32(4):236-243
pubmed: 29909644
Curr Allergy Asthma Rep. 2018 Oct 29;18(12):73
pubmed: 30374908
J Allergy Clin Immunol. 2013 Jan;131(1):230-2
pubmed: 23141739
Allergy. 2007 Mar;62(3):317-24
pubmed: 17298350
Allergy. 2017 May;72(5):713-722
pubmed: 27874202
Clin Exp Allergy. 2019 Mar;49(3):341-349
pubmed: 30176088
Front Allergy. 2021 Sep 23;2:721851
pubmed: 35386974
Rhinology. 2019 Jun 1;57(3):162-168
pubmed: 30810118
Allergy. 2016 Jul;71(7):967-76
pubmed: 26864207
Allergy. 2014 Jul;69(7):854-67
pubmed: 24761804
J Med Internet Res. 2020 Mar 16;22(3):e16642
pubmed: 32175909
Pediatr Allergy Immunol. 2013 Dec;24(8):742-51
pubmed: 24236692
J Allergy Clin Immunol. 2012 Mar;129(3):834-839.e8
pubmed: 22206774
Asia Pac Allergy. 2018 Jan 25;8(1):e7
pubmed: 29423374
Eur Ann Allergy Clin Immunol. 2021 Sep;53(5):228-233
pubmed: 32551465